Thomas C. Freyman, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 19,800 shares at $49.19 ($974K) on 2011-08-05, disclosed to the SEC on 2011-08-09.
Scheduled sale ($974k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.19 | 100 | $5K | 0.5% |
| 2 | $49.19 | 9,500 | $467K | 48.0% |
| 3 | $49.19 | 10,200 | $502K | 51.5% |
| Total | $49.19 avg | 19,800 | $974K | 100% |
| Filing → |
| TEN | BUY | 2018-08-10 | $222K | — | Filing → |
| ABT | SELL | 2014-03-04 | $117K | — | Filing → |
| TEN | BUY | 2013-05-03 | $57K | — | Filing → |